N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt
N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt (CAS:201409-23-6) is a chiral, functionalized amino-acid derivative supplied as a stable lithium salt. It serves as a key enantiopure building block in the synthesis of pharmaceutical actives and fine chemical intermediates, offering defined stereochemistry, high HPLC purity and good solubility for solution-phase transformations. With its Reagent Grade designation, every lot carries a complete certificate of analysis including assay, purity and physical data, giving QC teams everything needed for release testing. The product is backed by flexible 25kg/drum, 25kg/bag packaging, steady stock availability and export documentation, so customers can plan procurement with confidence and keep production running without interruption.
KieRay Chem is recognized as a reliable partner for N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt (CAS:201409-23-6), with dedicated production capacity, strict process control and a proven global track record. Batch-to-batch reproducibility is guaranteed by standardized production and full QC release, with COA, technical datasheets and safety files delivered with every order. Customized grades, pack sizes and dependable delivery schedules help customers maintain uninterrupted production and end-product quality worldwide. With a strong export record and customer-first service, KieRay Chem ensures every tonne of product meets the highest standards of purity and safety.
## N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt (CAS 201409-23-6): Key Functions and Uses
1. **Specialized Pharmaceutical Research Compound**
This lithium salt is a structurally defined thiazole–valine derivative used primarily in pharmaceutical and biochemical research. Its molecular structure combines an L-valine-derived moiety, a thiazole ring, and a lithium carboxylate salt form.
2. **Pharmaceutical Intermediate Development**
CAS 201409-23-6 may be used as a specialized intermediate or reference compound during the discovery and development of pharmaceutical candidates. It can support synthetic route design, structure–activity relationship studies, impurity profiling, and process-development research.
3. **Lithium Salt for Improved Formulation Handling**
Converting the carboxylic-acid functionality into a lithium salt can provide a defined ionic form with distinct solubility, crystallinity, stability, and handling characteristics. Actual performance depends on solvent, pH, temperature, water content, and formulation conditions.
4. **Thiazole-Containing Molecule for Medicinal Chemistry**
The thiazole ring is a valuable structural motif in medicinal chemistry. This compound can be used to investigate how thiazole substitution, L-valine configuration, and urea-like functional groups influence molecular recognition and biological activity.
5. **Biochemical and Proteomics Research**
The product is available from research-chemical suppliers for biochemical and proteomics-related studies. It may serve as a research reagent, analytical reference, or compound-screening material in controlled laboratory workflows.
6. **Analytical Method and Quality-Control Research**
Researchers can use CAS 201409-23-6 to develop or validate analytical methods such as HPLC, LC–MS, NMR, and related techniques. These methods help confirm identity, purity, salt form, degradation behavior, and batch consistency.
7. **Quality and Procurement Considerations**
When sourcing this product, buyers should verify the exact chemical name, CAS Number **201409-23-6**, molecular formula, molecular weight, purity, stereochemical specification, salt form, residual solvents, water content, certificate of analysis, and storage conditions. Useful SEO keywords include **N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt, CAS 201409-23-6, thiazole valine derivative, lithium carboxylate, pharmaceutical intermediate, medicinal chemistry reagent, and biochemical research compound**.
8. **Research-Use and Regulatory Notice**
This material should be described as a **research and development compound** unless a specific pharmaceutical approval and formulation are documented. It is not automatically an approved drug, active pharmaceutical ingredient, nutritional ingredient, or therapeutic product. Users should follow the supplier’s Safety Data Sheet, certificate of analysis, applicable regulations, and validated laboratory procedures.
Product Name: N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl-L-valine Lithium Salt
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.